439 related articles for article (PubMed ID: 11230470)
1. Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology.
Grill J; Le Deley MC; Gambarelli D; Raquin MA; Couanet D; Pierre-Kahn A; Habrand JL; Doz F; Frappaz D; Gentet JC; Edan C; Chastagner P; Kalifa C;
J Clin Oncol; 2001 Mar; 19(5):1288-96. PubMed ID: 11230470
[TBL] [Abstract][Full Text] [Related]
2. Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study.
Grundy RG; Wilne SA; Weston CL; Robinson K; Lashford LS; Ironside J; Cox T; Chong WK; Campbell RH; Bailey CC; Gattamaneni R; Picton S; Thorpe N; Mallucci C; English MW; Punt JA; Walker DA; Ellison DW; Machin D;
Lancet Oncol; 2007 Aug; 8(8):696-705. PubMed ID: 17644039
[TBL] [Abstract][Full Text] [Related]
3. Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors.
Mason WP; Grovas A; Halpern S; Dunkel IJ; Garvin J; Heller G; Rosenblum M; Gardner S; Lyden D; Sands S; Puccetti D; Lindsley K; Merchant TE; O'Malley B; Bayer L; Petriccione MM; Allen J; Finlay JL
J Clin Oncol; 1998 Jan; 16(1):210-21. PubMed ID: 9440745
[TBL] [Abstract][Full Text] [Related]
4. Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group.
Geyer JR; Zeltzer PM; Boyett JM; Rorke LB; Stanley P; Albright AL; Wisoff JH; Milstein JM; Allen JC; Finlay JL
J Clin Oncol; 1994 Aug; 12(8):1607-15. PubMed ID: 8040673
[TBL] [Abstract][Full Text] [Related]
5. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
Geyer JR; Sposto R; Jennings M; Boyett JM; Axtell RA; Breiger D; Broxson E; Donahue B; Finlay JL; Goldwein JW; Heier LA; Johnson D; Mazewski C; Miller DC; Packer R; Puccetti D; Radcliffe J; Tao ML; Shiminski-Maher T;
J Clin Oncol; 2005 Oct; 23(30):7621-31. PubMed ID: 16234523
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood.
Needle MN; Goldwein JW; Grass J; Cnaan A; Bergman I; Molloy P; Sutton L; Zhao H; Garvin JH; Phillips PC
Cancer; 1997 Jul; 80(2):341-7. PubMed ID: 9217048
[TBL] [Abstract][Full Text] [Related]
7. Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy--results of the first French prospective study for the French Society of Pediatric Oncology.
Laithier V; Grill J; Le Deley MC; Ruchoux MM; Couanet D; Doz F; Pichon F; Rubie H; Frappaz D; Vannier JP; Babin-Boilletot A; Sariban E; Chastagner P; Zerah M; Raquin MA; Hartmann O; Kalifa C;
J Clin Oncol; 2003 Dec; 21(24):4572-8. PubMed ID: 14673044
[TBL] [Abstract][Full Text] [Related]
8. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
[TBL] [Abstract][Full Text] [Related]
9. High-grade glioma in children under 5 years of age: a chemotherapy only approach with the BBSFOP protocol.
Dufour C; Grill J; Lellouch-Tubiana A; Puget S; Chastagner P; Frappaz D; Doz F; Pichon F; Plantaz D; Gentet JC; Raquin MA; Kalifa C
Eur J Cancer; 2006 Nov; 42(17):2939-45. PubMed ID: 16962317
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemotherapy for brain tumors in infants and young children.
Iwama J; Ogiwara H; Kiyotani C; Terashima K; Matsuoka K; Iwafuchi H; Morota N
J Neurosurg Pediatr; 2015 May; 15(5):488-92. PubMed ID: 25723725
[TBL] [Abstract][Full Text] [Related]
11. Adult medulloblastoma: multiagent chemotherapy.
Greenberg HS; Chamberlain MC; Glantz MJ; Wang S
Neuro Oncol; 2001 Jan; 3(1):29-34. PubMed ID: 11305414
[TBL] [Abstract][Full Text] [Related]
12. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors.
Duffner PK; Horowitz ME; Krischer JP; Friedman HS; Burger PC; Cohen ME; Sanford RA; Mulhern RK; James HE; Freeman CR
N Engl J Med; 1993 Jun; 328(24):1725-31. PubMed ID: 8388548
[TBL] [Abstract][Full Text] [Related]
13. Ependymal tumors in childhood.
Agaoglu FY; Ayan I; Dizdar Y; Kebudi R; Gorgun O; Darendeliler E
Pediatr Blood Cancer; 2005 Sep; 45(3):298-303. PubMed ID: 15770637
[TBL] [Abstract][Full Text] [Related]
14. Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue.
Zacharoulis S; Levy A; Chi SN; Gardner S; Rosenblum M; Miller DC; Dunkel I; Diez B; Sposto R; Ji L; Asgharzadeh S; Hukin J; Belasco J; Dubowy R; Kellie S; Termuhlen A; Finlay J
Pediatr Blood Cancer; 2007 Jul; 49(1):34-40. PubMed ID: 16874765
[TBL] [Abstract][Full Text] [Related]
15. Synchronous radiochemotherapy in unfavorable brain tumors of children and young adults.
Urban C; Benesch M; Pakisch B; Lackner H; Kerbl R; Schwinger W; Oberbauer R
J Neurooncol; 1998 Aug; 39(1):71-80. PubMed ID: 9760072
[TBL] [Abstract][Full Text] [Related]
16. Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study.
Massimino M; Gandola L; Giangaspero F; Sandri A; Valagussa P; Perilongo G; Garrè ML; Ricardi U; Forni M; Genitori L; Scarzello G; Spreafico F; Barra S; Mascarin M; Pollo B; Gardiman M; Cama A; Navarria P; Brisigotti M; Collini P; Balter R; Fidani P; Stefanelli M; Burnelli R; Potepan P; Podda M; Sotti G; Madon E;
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1336-45. PubMed ID: 15050308
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy for unresectable and recurrent intramedullary glial tumours in children. Brain Tumours Subcommittee of the French Society of Paediatric Oncology (SFOP).
Doireau V; Grill J; Zerah M; Lellouch-Tubiana A; Couanet D; Chastagner P; Marchal JC; Grignon Y; Chouffai Z; Kalifa C
Br J Cancer; 1999 Nov; 81(5):835-40. PubMed ID: 10555754
[TBL] [Abstract][Full Text] [Related]
18. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566
[TBL] [Abstract][Full Text] [Related]
19. MOPP chemotherapy without irradiation as primary postsurgical therapy for brain tumors in infants and young children.
Ater JL; van Eys J; Woo SY; Moore B; Copeland DR; Bruner J
J Neurooncol; 1997 May; 32(3):243-52. PubMed ID: 9049886
[TBL] [Abstract][Full Text] [Related]
20. Postoperative chemotherapy in children less than 4 years of age with malignant brain tumors: promising initial response to a VETOPEC-based regimen. A Study of the Australian and New Zealand Children's Cancer Study Group (ANZCCSG).
White L; Kellie S; Gray E; Toogood I; Waters K; Lockwood L; Macfarlane S; Johnston H
J Pediatr Hematol Oncol; 1998; 20(2):125-30. PubMed ID: 9544162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
